Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5622021 | Thrombosis Research | 2017 | 19 Pages |
Abstract
Warfarinized thrombocytopenic patients are at higher risk of minor bleeding complications with a higher tendency for major bleeding but derive similar benefits against thrombotic events compared to normal patients. Bleeding events are associated with higher INRs. A narrow INR target with an upper limit below 2.5 together with closer anticoagulation monitoring may improve safety of patients.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Y.F. Lai, D.Y.T. Goh, S.Y. How, K.Y. Lee, V.W.P. Tham, M.C. Kong, C.W. Tan, H.J. Ng,